US · bci · biomaterials · neurotech
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series A · Jun 2026 · $55M
C.P. Group Innovation lead, Alumni Ventures, Gaorong Ventures, Hillhouse Investment, Stanford President’s Venture Fund
Reported by Ventureburn · SEC filing: $34M sold under the offering
Missing a round, or an investor who was in one? Tell us.